Impact of Lactiplantibacillus plantarum Inducia on metabolic and antioxidative response in cholesterol and BMI variable indices: randomised, double-blind, placebo-controlled trials
In: Beneficial MicrobesInstitute of Biomedicine and Translational Medicine, Department of Microbiology, University of Tartu, 19 Ravila, 50411 Tartu, Estonia.
Search for other papers by J. Štšepetova in
Current site
Google Scholar
Search for other papers by M. Rätsep in
Current site
Google Scholar
Search for other papers by O. Gerulis in
Current site
Google Scholar
Search for other papers by A. Jõesaar in
Current site
Google Scholar
Institute of Biomedicine and Translational Medicine, Department of Microbiology, University of Tartu, 19 Ravila, 50411 Tartu, Estonia.
Search for other papers by M. Mikelsaar in
Current site
Google Scholar
Search for other papers by E. Songisepp in
Current site
Google Scholar
Probiotics may have potential in reducing cardiovascular disease (CVD) risk in middle-aged persons with borderline metabolic indices. The ability of potential probiotic Lactiplantibacillus plantarum Inducia to reduce CVD risk factors in persons with variable cholesterol and body mass indices (BMI) was assessed. In two parallel-armed double-blind placebo-controlled interventions (n=136) and (n=104), participants daily received either test yoghurt (Inducia) or placebo yoghurt. BMI, blood pressure, plasma glucose, cholesterol, high-sensitivity C-reactive protein (hs-CRP), oxidative stress and immunological markers were measured. Total counts of lactobacilli and L. plantarum Inducia were evaluated using real-time PCR. Significant reduction of total cholesterol, low density lipoprotein cholesterol (LDL-c) and non-high-density cholesterol occurred in both trials. The change in cholesterol (P=0.023) in persons with normal BMI and borderline cholesterol levels after four weeks of yoghurt consumption was detected. A difference was also found between placebo and test yoghurt groups (P=0.042) in LDL-c with normal BMI. Blood glucose reduction (P=0.01) and antioxidative effect was detected in overweight volunteers of the test yoghurt group. The suppression of oxidised LDL was associated with lowered oxidative stress index and total peroxide concentration values and faecal recovery of Inducia. The Inducia strain expresses antioxidative effect on blood lipids and has anti-glycaemic impact that allow to apply it as dietary probiotic supplement for the management of CVD risks in humans.
-
Ahmad, A.F., Dwivedi, G., O’Gara, F., Caparros-Martin, J. and Ward, N.C., 2019. The gut microbiome and cardiovascular disease: current knowledge and clinical potential. American Journal of Physiology – Heart and Circulatory Physiology 317: H923-H938. https://doi.org/10.1152/ajpheart.00376.2019
-
Amaretti, A., di Nunzio, M., Pompei, A., Raimondi, S., Rossi, M. and Bordoni, A., 2013. Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Applied Microbiology and Biotechnology 97: 809-817. https://doi.org/10.1007/s00253-012-4241-7
-
Anagnostis, P., Paschou, S.A., Katsiki, N., Krikidis, D., Lambrinoudaki, I. and Goulis, D.G., 2019. Menopausal hormone therapy and cardiovascular risk: where are we now? Current Vascular Pharmacology 17: 564-572. https://doi.org/10.2174/1570161116666180709095348
-
Aoun, A., Darwish, F. and Hamod, N., 2020. The influence of the gut microbiome on obesity in adults and the role of probiotics, prebiotics, and synbiotics for weight loss. Preventive Nutrition and Food Science 25: 113-123. https://doi.org/10.3746/pnf.2020.25.2.113
-
Aron-Wisnewsky, J., Warmbrunn, M.V., Nieuwdorp, M. and Clement, K., 2021. Metabolism and metabolic disorders and the microbiome: the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology 160: 573-599. https://doi.org/10.1053/j.gastro.2020.10.057
-
Ataie-Jafari, A., Larijani, B., Alavi Majd, H. and Tahbaz, F., 2009. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Annals of Nutrition and Metabolism 54: 22-27. https://doi.org/10.1159/000203284
-
Ayer, J., Charakida, M., Deanfield, J.E. and Celermajer, D.S., 2015. Lifetime risk: childhood obesity and cardiovascular risk. European Heart Journal 36: 1371-1376. https://doi.org/10.1093/eurheartj/ehv089
-
Bastien, M., Poirier, P., Lemieux, I. and Despres, J.P., 2014. Overview of epidemiology and contribution of obesity to cardiovascular disease. Progress in Cardiovascular Diseases 56: 369-381. https://doi.org/10.1016/j.pcad.2013.10.016
-
Behera, S.S., Ray, R.C. and Zdolec, N., 2018. Lactobacillus plantarum with functional properties: an approach to increase safety and shelf-life of fermented foods. Biomed Research International 2018: 9361614. https://doi.org/10.1155/2018/9361614
-
Bogers, R.P., Bemelmans, W.J., Hoogenveen, R.T., Boshuizen, H.C., Woodward, M., Knekt, P., Van Dam, R.M., Hu, F.B., Visscher, T.L., Menotti, A., Thorpe, R.J., Jr., Jamrozik, K., Calling, S., Strand, B.H., Shipley, M.J. and Investigators, B.-C.C., 2007. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300,000 persons. Archives of Internal Medicine 167: 1720-1728. https://doi.org/10.1001/archinte.167.16.1720
-
Broccali, G., Berti, M., Pistolesi, E. and Cestaro, B., 2000. Study of the effect of Lactobacillus GG supplementation in combination with and without arginine aspartate on lipoproteins and liver peroxidation in cholesterol-fed rats. International Journal of Food Science and Nutrition 51: 475-482. https://doi.org/10.1080/09637480050208080
-
Bruno-Barcena, J.M., Andrus, J.M., Libby, S.L., Klaenhammer, T.R. and Hassan, H.M., 2004. Expression of a heterologous manganese superoxide dismutase gene in intestinal lactobacilli provides protection against hydrogen peroxide toxicity. Applied and Environmental Microbiology 70: 4702-4710. https://doi.org/10.1128/AEM.70.8.4702-4710.2004
-
Carbone, S., Canada, J.M., Billingsley, H.E., Siddiqui, M.S., Elagizi, A. and Lavie, C.J., 2019. Obesity paradox in cardiovascular disease: where do we stand? Vascular Health Risk Management 15: 89-100. https://doi.org/10.2147/VHRM.S168946
-
Chaiyasut, C., Sivamaruthi, B.S., Kesika, P., Khongtan, S., Khampithum, N., Thangaleela, S., Peerajan, S., Bumrungpert, A., Chaiyasut, K., Sirilun, S. and Sittiprapaporn, P., 2021. Synbiotic supplementation improves obesity index and metabolic biomarkers in Thai obese adults: a randomized clinical trial. Foods 10. https://doi.org/10.3390/foods10071580
-
Chen, J., Soede, N.M., Van Dorland, H.A., Remmelink, G.J., Bruckmaier, R.M., Kemp, B. and Van Knegsel, A.T., 2015. Relationship between metabolism and ovarian activity in dairy cows with different dry period lengths. Theriogenology 84: 1387-1396. https://doi.org/10.1016/j.theriogenology.2015.07.025
-
Chen, Y., Copeland, W.K., Vedanthan, R., Grant, E., Lee, J.E., Gu, D., Gupta, P.C., Ramadas, K., Inoue, M., Tsugane, S., Tamakoshi, A., Gao, Y.T., Yuan, J.M., Shu, X.O., Ozasa, K., Tsuji, I., Kakizaki, M., Tanaka, H., Nishino, Y., Chen, C.J., Wang, R., Yoo, K.Y., Ahn, Y.O., Ahsan, H., Pan, W.H., Chen, C.S., Pednekar, M.S., Sauvaget, C., Sasazuki, S., Yang, G., Koh, W.P., Xiang, Y.B., Ohishi, W., Watanabe, T., Sugawara, Y., Matsuo, K., You, S.L., Park, S.K., Kim, D.H., Parvez, F., Chuang, S.Y., Ge, W., Rolland, B., McLerran, D., Sinha, R., Thornquist, M., Kang, D., Feng, Z., Boffetta, P., Zheng, W., He, J. and Potter, J.D., 2013. Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium. BMJ 347: f5446. https://doi.org/10.1136/bmj.f5446
-
Cho, E.J., Min, Y.J., Oh, M.S., Kwon, J.E., Kim, J.E., Lee, W.S., Lee, K.J., Kim, S.W., Kim, T.H., Kim, M.A., Kim, C.J. and Ryu, W.S., 2011. Effects of the transition from premenopause to postmenopause on lipids and lipoproteins: quantification and related parameters. Korean Journal of Internal Medicine 26: 47-53. https://doi.org/10.3904/kjim.2011.26.1.47
-
Costabile, A., Buttarazzi, I., Kolida, S., Quercia, S., Baldini, J., Swann, J.R., Brigidi, P. and Gibson, G.R., 2017. An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults. PLoS ONE 12: e0187964. https://doi.org/10.1371/journal.pone.0187964
-
Dixon, A., Robertson, K., Yung, A., Que, M., Randall, H., Wellalagodage, D., Cox, T., Robertson, D., Chi, C. and Sun, J., 2020. Efficacy of probiotics in patients of cardiovascular disease risk: a systematic review and meta-analysis. Current Hypertension Reports 22: 74. https://doi.org/10.1007/s11906-020-01080-y
-
European Food Safety Authority (EFSA), 2012. Panel on biological hazards (BIOHAZ): scientific opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2012 update). EFSA Journal 10: 3020.
-
El-Mikkawy, D.M.E., EL-Sadek, M.A., EL-Badawy, M.A. and El-Mikkawy, D.S., 2020. Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity. Egyptian Rheumatology and Rehabilitation 47: 7. https://doi.org/10.1186/s43166-020-00003-8
-
Erel, O., 2004. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 37: 112-119. https://doi.org/https://doi.org/10.1016/j.clinbiochem.2003.10.014
-
Fantuzzi, G., 2005. Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology 115: 911-919; quiz 920. https://doi.org/10.1016/j.jaci.2005.02.023
-
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: http://tinyurl.com/zdbrkeg.
-
Food and Drug Administration (FDA), 2019. Notice to US Food and Drug Administration of the conclusion that the intended use of Lactobacillus plantarum ECGC 13110402 (LPLDL®) is generally recognized as safe. GRN Notice 847 of the Division of Biotechnology and GRAS Notice Review Office of Food Additive Safety (HFS-200) Center for Food Safety and Applied Nutrition FDA Department of Health and Human Services.
-
Feng, T. and Wang, J., 2020. Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review. Gut Microbes 12: 1801944. https://doi.org/10.1080/19490976.2020.1801944
-
Fidanza, M., Panigrahi, P. and Kollmann, T.R., 2021. Lactiplantibacillus plantarum-Nomad and ideal probiotic. Frontiers in Microbiology 12: 712236. https://doi.org/10.3389/fmicb.2021.712236
-
Fuentes, M.C., Lajo, T., Carrion, J.M. and Cune, J., 2013. Cholesterollowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults. British Journal of Nutrition 109: 1866-1872. https://doi.org/10.1017/S000711451200373X
-
Gobel, R.J., Larsen, N., Jakobsen, M., Molgaard, C. and Michaelsen, K.F., 2012. Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome. Journal of Pediatric Gastroenterology and Nutrition 55: 673-678. https://doi.org/10.1097/MPG.0b013e318263066c
-
Gupta, A., Mann, B., Kumar, R. and Sangwan, R., 2009. Antioxidant activity of Cheddar cheeses at different stages of ripening. International Journal of Dairy Technology 62: 339-347.
'Antioxidant activity of Cheddar cheeses at different stages of ripening ' () 62 International Journal of Dairy Technology : 339 -347.
-
Harmon, M.E., Campen, M.J., Miller, C., Shuey, C., Cajero, M., Lucas, S., Pacheco, B., Erdei, E., Ramone, S., Nez, T. and Lewis, J., 2016. Associations of circulating oxidized LDL and conventional biomarkers of cardiovascular disease in a cross-sectional study of the Navajo population. PLoS ONE 11: e0143102. https://doi.org/10.1371/journal.pone.0143102
-
Henning, T. and Weber, D., 2021. Redox biomarkers in dietary interventions and nutritional observation studies – from new insights to old problems. Redox Biology 41: 101922. https://doi.org/10.1016/j.redox.2021.101922
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews: Gastroenterology & Hepatology 11: 506-514. https://doi.org/10.1038/nrgastro.2014.66
-
Ho, C., Gao, Y., Zheng, D., Liu, Y., Shan, S., Fang, B., Zhao, Y., Song, D., Zhang, Y. and Li, Q., 2019. Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK/ACC/SREBP-1c pathway. Journal of Cellular and Molecular Medicine 23: 5108-5118. https://doi.org/10.1111/jcmm.14380
-
Ho, H.V., Sievenpiper, J.L., Zurbau, A., Blanco Mejia, S., Jovanovski, E., Au-Yeung, F., Jenkins, A.L. and Vuksan, V., 2016. The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. British Journal of Nutrition 116: 1369-1382. https://doi.org/10.1017/S000711451600341XI
-
yen, B., Weng, S., Vinogradova, Y., Akyea, R.K., Qureshi, N. and Kai, J., 2021. Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality: a cohort study of over 260,000 adults in the UK. BMC Public Health 21: 576. https://doi.org/10.1186/s12889-021-10606-1
-
Jeong, S.J., Park, J.G. and Oh, G.T., 2021. Peroxiredoxins as potential targets for cardiovascular disease. Antioxidants 10: 1244. https://doi.org/10.3390/antiox10081244
-
Kanda, T. and Takahashi, T., 2004. Interleukin-6 and cardiovascular diseases. Japanese Heart Journal 45: 183-193. https://doi.org/10.1536/jhj.45.183
-
Karamese, M., Aydin, H., Sengul, E., Gelen, V., Sevim, C., Ustek, D. and Karakus, E., 2016. The immunostimulatory effect of lactic acid bacteria in a rat model. Iranian Journal of Immunology 13: 220-228. https://doi.org/IJIv13i3A7
-
Kaur, S., Kingo, K. and Zilmer, M., 2017. Psoriasis and cardiovascular risk-do promising new biomarkers have clinical impact? Mediators of Inflammation 2017: 7279818. https://doi.org/10.1155/2017/7279818
-
Khalesi, S., Bellissimo, N., Vandelanotte, C., Williams, S., Stanley, D. and Irwin, C., 2019. A review of probiotic supplementation in healthy adults: helpful or hype? European Journal of Clinical Nutrition 73: 24-37. https://doi.org/10.1038/s41430-018-0135-9
-
Khan, S.S., Carnethon, M.R. and Lloyd-Jones, D.M., 2018a. The obesity paradigm and lifetime risk of cardiovascular disease-reply. JAMA Cardiology 3: 896-897. https://doi.org/10.1001/jamacardio.2018.1840
-
Khan, S.S., Ning, H., Wilkins, J.T., Allen, N., Carnethon, M., Berry, J.D., Sweis, R.N. and Lloyd-Jones, D.M., 2018b. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiology 3: 280-287. https://doi.org/10.1001/jamacardio.2018.0022
-
Kiessling, G., Schneider, J. and Jahreis, G., 2002. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. European Journal of Clinical Nutrition 56: 843-849. https://doi.org/10.1038/sj.ejcn.1601399
-
Klein, D., 2002. Quantification using real-time PCR technology: applications and limitations. Trends in Molecular Medicine 8: 257-260. https://doi.org/10.1016/s1471-4914(02)02355-9
-
Kullisaar, T., Songisepp, E., Aunapuu, M., Kilk, K., Arend, A., Mikelsaar, M., Rehema, A. and Zilmer, M., 2010. Complete glutathione system in probiotic Lactobacillus fermentum ME-3. Prikladnaya Biokhimiya i Mikrobiologiya 46: 527-531.
'Complete glutathione system in probiotic Lactobacillus fermentum ME-3 ' () 46 Prikladnaya Biokhimiya i Mikrobiologiya : 527 -531.
-
Kullisaar, T., Songisepp, E., Mikelsaar, M., Zilmer, K., Vihalemm, T. and Zilmer, M., 2003. Antioxidative probiotic fermented goats’ milk decreases oxidative stress-mediated atherogenicity in human subjects. British Journal of Nutrition 90: 449-456. https://doi.org/10.1079/bjn2003896
-
Kullisaar, T., Zilmer, M., Mikelsaar, M., Vihalemm, T., Annuk, H., Kairane, C. and Kilk, A., 2002. Two antioxidative lactobacilli strains as promising probiotics. International Journal of Food Microbiology 72: 215-224. https://doi.org/10.1016/s0168-1605(01)00674-2
-
Le, B. and Yang, S.H., 2018. Probiotic potential of novel Lactobacillus strains isolated from salted-fermented shrimp as antagonists for Vibrio parahaemolyticus. Journal of Microbiology 56: 138-144. https://doi.org/10.1007/s12275-018-7407-x
-
Lehrskov, L.L., Dorph, E., Widmer, A.M., Hepprich, M., Siegenthaler, J., Timper, K. and Donath, M.Y., 2018. The role of IL-1 in postprandial fatigue. Molecular Metabolism 12: 107-112. https://doi.org/10.1016/j.molmet.2018.04.001
-
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P.A., Moser, A.B., Desimone, C., Song, X.Y. and Diehl, A.M., 2003. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37: 343-350. https://doi.org/10.1053/jhep.2003.50048
-
Linton, M.R.F., Yancey, P.G., Davies, S.S., Jerome, W.G., Linton, E.F., Song, W.L., Doran, A.C. and Vickers, K.C., 2000. The role of lipids and lipoproteins in atherosclerosis. In: Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., De Herder, W.W., Dhatariya, K., Dungan, K., Hershman, J.M., Hofland, J., Kalra, S., Kaltsas, G., Koch, C., Kopp, P., Korbonits, M., Kovacs, C.S., Kuohung, W., Laferrere, B., Levy, M., McGee, E.A., McLachlan, R., Morley, R., New, M., Purnell, J., Sahay, R., Singer, F., Sperling, M.A., Stratakis, C.A., Trence, D.L. and Wilson, D.P. (eds) Endotext, South Dartmouth, MA, USA.
'The role of lipids and lipoproteins in atherosclerosis', ().
-
Madjd, A., Taylor, M.A., Mousavi, N., Delavari, A., Malekzadeh, R., Macdonald, I.A. and Farshchi, H.R., 2016. Comparison of the effect of daily consumption of probiotic compared with low-fat conventional yogurt on weight loss in healthy obese women following an energy-restricted diet: a randomized controlled trial. American Journal of Clinical Nutrition 103: 323-329. https://doi.org/10.3945/ajcn.115.120170
-
Mafi, A., Namazi, G., Soleimani, A., Bahmani, F., Aghadavod, E. and Asemi, Z., 2018. Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Food and Function 9: 4763-4770. https://doi.org/10.1039/c8fo00888d
-
Manzoor, A. and Tayyeb, A., 2019. Functional probiotic attributes and gene encoding plantaracin among variant Lactobacillus plantarum strains. Microbial Pathogenesis 131: 22-32. https://doi.org/10.1016/j.micpath.2019.03.016
-
Meyer, A.L., Elmadfa, I., Herbacek, I. and Micksche, M., 2007. Probiotic, as well as conventional yogurt, can enhance the stimulated production of proinflammatory cytokines. Journal of Human Nutrition and Dietetics 20: 590-598. https://doi.org/10.1111/j.1365-277X.2007.00807.x
-
Mikelsaar, M., Stsepetova, J., Mikelsaar, R.-H., Truusalu, K., Smidt, I., Hütt, P.e., Rätsep, M.e. and Songisepp, E., 2020. Polyamines of human strain Lactobacillus plantarum Inducia induce modulation of innate immune markers. Journal of Functional Foods 72: 104064. https://doi.org/https://doi.org/10.1016/j.jff.2020.104064
-
Mishra, V., Shah, C., Mokashe, N., Chavan, R., Yadav, H. and Prajapati, J., 2015. Probiotics as potential antioxidants: a systematic review. Journal of Agriculture and Food Chemistry 63: 3615-3626. https://doi.org/10.1021/jf506326t
-
Mitev, K. and Taleski, V., 2019. Association between the gut microbiota and obesity. Open Access Macedonian Journal of Medical Sciences 7: 2050-2056. https://doi.org/10.3889/oamjms.2019.586
-
Mo, R., Zhang, X. and Yang, Y., 2019. Effect of probiotics on lipid profiles in hypercholesterolaemic adults: a meta-analysis of randomized controlled trials. Medicina Clínica 152: 473-481. https://doi.org/10.1016/j.medcli.2018.09.007
-
Novakovic, M., Rout, A., Kingsley, T., Kirchoff, R., Singh, A., Verma, V., Kant, R. and Chaudhary, R., 2020. Role of gut microbiota in cardiovascular diseases. World Journal of Cardiology 12: 110-122. https://doi.org/10.4330/wjc.v12.i4.110
-
Oxman, T., Shapira, M., Diver, A., Klein, R., Avazov, N. and Rabinowitz, B., 2000. A new method of long-term preventive cardioprotection using Lactobacillus. American Journal of Physiology Heart and Circulatory Physiology 278: H1717-1724. https://doi.org/10.1152/ajpheart.2000.278.5.H1717
-
Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., 3rd, Criqui, M., Fadl, Y.Y., Fortmann, S.P., Hong, Y., Myers, G.L., Rifai, N., Smith, S.C., Jr., Taubert, K., Tracy, R.P. and Vinicor, F., 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511. https://doi.org/10.1161/01.cir.0000052939.59093.45
-
Perna, A., Intaglietta, I., Simonetti, A. and Gambacorta, E., 2013. Effect of genetic type and casein haplotype on antioxidant activity of yogurts during storage. Journal of Dairy Science 96: 3435-3441. https://doi.org/10.3168/jds.2012-5859
-
Piepoli, M.F., Hoes, A.W., Agewall, S., Albus, C., Brotons, C., Catapano, A.L., Cooney, M.T., Corra, U., Cosyns, Cosyns, B., Deaton, C., Graham, I., Hall, M.S., Hobbs, F.D.R., Lochen, M.L., Lollgen, H., Marques-Vidal, P., Perk, J., Prescott, E., Redon, J., Richter, D.J., Sattar, N., Smulders, Y., Tiberi, M., Van der Worp, H.B., Van Dis, I. and Verschuren, W.M.M., 2016. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Revista Española de Cardiología (English Edition) 69: 939. https://doi.org/10.1016/j.rec.2016.09.009
-
Pophaly, S.D., Singh, R., Pophaly, S.D., Kaushik, J.K. and Tomar, S.K., 2012. Current status and emerging role of glutathione in food grade lactic acid bacteria. Microbial Cell Factories 11: 114. https://doi.org/10.1186/1475-2859-11-114
-
Sah, B.N.P., Vasiljevic, T., McKechnie, S. and Donkor, O.N., 2018. Antioxidative and antibacterial peptides derived from bovine milk proteins. Critical Reviews in Food Science and Nutrition 58: 726-740. https://doi.org/10.1080/10408398.2016.1217825
-
Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., Ngom-Bru, C., Berger, B., Philippe, L., Ammon-Zuffrey, C., Leone, P., Chevrier, G., St-Amand, E., Marette, A., Dore, J. and Tremblay, A., 2014. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition 111: 1507-1519. https://doi.org/10.1017/S0007114513003875
-
Songisepp, E., Stsepetova, J., Rätsep, M., Kuus, L., Kilk, K., Vallas, M. and Mikelsaar, M., 2022. Polyfunctional metabolic properties of the human strain Lactiplantibacillus plantarum Inducia (DSM 21379): experimental and clinical approaches. Journal of Functional Foods 92: 105064. https://doi.org/10.1016/j.jff.2022.105064
-
Strobel, N.A., Fassett, R.G., Marsh, S.A. and Coombes, J.S., 2011. Oxidative stress biomarkers as predictors of cardiovascular disease. International Journal of Cardiology 147: 191-201. https://doi.org/10.1016/j.ijcard.2010.08.008
-
Taylor, M.J. and Richardson, T., 1980. Antioxidant activity of skim milk: effect of sonication. Journal of Dairy Science 63: 1938-1942. https://doi.org/10.3168/jds.S0022-0302(80)83161-4
-
Terahara, M., Nishide, S. and Kaneko, T., 2000. Preventive effect of Lactobacillus delbrueckii subsp. bulgaricus on the oxidation of LDL. Bioscience Biotechnology and Biochemistry 64: 1868-1873. https://doi.org/10.1271/bbb.64.1868
-
Truusalu, K., Kullisaar, T., Hutt, P., Mahlapuu, R., Aunapuu, M., Arend, A., Zilmer, M., Mikelsaar, R.H. and Mikelsaar, M., 2010. Immunological, antioxidative, and morphological response in combined treatment of ofloxacin and Lactobacillus fermentum ME-3 probiotic in Salmonella Typhimurium murine model. APMIS 118: 864-872. https://doi.org/10.1111/j.1600-0463.2010.02672.x
-
Van Ommen, B., Van der Greef, J., Ordovas, J.M. and Daniel, H., 2014. Phenotypic flexibility as key factor in the human nutrition and health relationship. Genes and Nutrition 9: 423. https://doi.org/10.1007/s12263-014-0423-5
-
Wang, Y., Wu, Y., Wang, Y., Xu, H., Mei, X., Yu, D., Wang, Y. and Li, W., 2017. Antioxidant properties of probiotic bacteria. Nutrients 9: 521. https://doi.org/10.3390/nu9050521
-
World Health Organization (WHO), 2021. Obesity and overweight. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
-
Wueest, S. and Konrad, D., 2020. The controversial role of IL-6 in adipose tissue on obesity-induced dysregulation of glucose metabolism. American Journal of Physiology – Endocrinology and Metabolism 319: E607-E613. https://doi.org/10.1152/ajpendo.00306.2020
-
Xiao, J.Z., Kondo, S., Takahashi, N., Miyaji, K., Oshida, K., Hiramatsu, A., Iwatsuki, K., Kokubo, S. and Hosono, A., 2003. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. Journal of Dairy Science 86: 2452-2461. https://doi.org/10.3168/jds.S0022-0302(03)73839-9
-
Xu, H., Wang, X., Feng, W., Liu, Q., Zhou, S., Liu, Q. and Cai, L., 2020. The gut microbiota and its interactions with cardiovascular disease. Microbial Biotechnology 13: 637-656. https://doi.org/10.1111/1751-7915.13524
-
Yilmaz-Ersan, L., Ozcan, T., Akpinar-Bayizit, A. and Sahin, S., 2018. Comparison of antioxidant capacity of cow and ewe milk kefirs. Journal of Dairy Science 101: 3788-3798. https://doi.org/10.3168/jds.2017-13871
-
Zheng, Z.Y., Cao, F.W., Wang, W.J., Yu, J., Chen, C., Chen, B., Liu, J.X., Firrman, J., Renye, J. and Ren, D.X., 2020. Probiotic characteristics of Lactobacillus plantarum E680 and its effect on hypercholesterolemic mice. BMC Microbiology 20: 239. https://doi.org/10.1186/s12866-020-01922-4
-
Zhu, W., Guo, S., Homilius, M., Nsubuga, C., Wright, S.H., Quan, D., Kc, A., Eddy, S.S., Victorio, R.A., Beerens, M., Flaumenhaft, R., Deo, R.C. and MacRae, C.A., 2022. PIEZO1 mediates a mechanothrombotic pathway in diabetes. Science Translational Medicine 14: eabk1707. https://doi.org/10.1126/scitranslmed.abk1707
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 482 | 350 | 35 |
| PDF Views & Downloads | 662 | 483 | 33 |
Impact of Lactiplantibacillus plantarum Inducia on metabolic and antioxidative response in cholesterol and BMI variable indices: randomised, double-blind, placebo-controlled trials
In: Beneficial MicrobesInstitute of Biomedicine and Translational Medicine, Department of Microbiology, University of Tartu, 19 Ravila, 50411 Tartu, Estonia.
Search for other papers by J. Štšepetova in
Current site
Google Scholar
PubMed
Search for other papers by M. Rätsep in
Current site
Google Scholar
PubMed
Search for other papers by O. Gerulis in
Current site
Google Scholar
PubMed
Search for other papers by A. Jõesaar in
Current site
Google Scholar
PubMed
Institute of Biomedicine and Translational Medicine, Department of Microbiology, University of Tartu, 19 Ravila, 50411 Tartu, Estonia.
Search for other papers by M. Mikelsaar in
Current site
Google Scholar
PubMed
Search for other papers by E. Songisepp in
Current site
Google Scholar
PubMed
Probiotics may have potential in reducing cardiovascular disease (CVD) risk in middle-aged persons with borderline metabolic indices. The ability of potential probiotic Lactiplantibacillus plantarum Inducia to reduce CVD risk factors in persons with variable cholesterol and body mass indices (BMI) was assessed. In two parallel-armed double-blind placebo-controlled interventions (n=136) and (n=104), participants daily received either test yoghurt (Inducia) or placebo yoghurt. BMI, blood pressure, plasma glucose, cholesterol, high-sensitivity C-reactive protein (hs-CRP), oxidative stress and immunological markers were measured. Total counts of lactobacilli and L. plantarum Inducia were evaluated using real-time PCR. Significant reduction of total cholesterol, low density lipoprotein cholesterol (LDL-c) and non-high-density cholesterol occurred in both trials. The change in cholesterol (P=0.023) in persons with normal BMI and borderline cholesterol levels after four weeks of yoghurt consumption was detected. A difference was also found between placebo and test yoghurt groups (P=0.042) in LDL-c with normal BMI. Blood glucose reduction (P=0.01) and antioxidative effect was detected in overweight volunteers of the test yoghurt group. The suppression of oxidised LDL was associated with lowered oxidative stress index and total peroxide concentration values and faecal recovery of Inducia. The Inducia strain expresses antioxidative effect on blood lipids and has anti-glycaemic impact that allow to apply it as dietary probiotic supplement for the management of CVD risks in humans.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 482 | 350 | 35 |
| PDF Views & Downloads | 662 | 483 | 33 |
